Syra Health terminates CEO Deepika Vuppalanchi for cause; CFO appointed interim CEO

Syra Health Corp

Board terminated CEO Deepika Vuppalanchi for cause on June 13, 2025.
Priya Prasad, previously CFO and COO, appointed interim CEO effective June 16, 2025.
Termination of employment agreement dated April 5, 2021 for cause.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Priya Prasad

Interim Chief Executive Officer

SYRA · Syra Health Corp

Effective: 2025-06-16
Filed: June 17, 2025, 7:59 PM ET

the Board of Directors of the Company appointed Priya Prasad, the Company’s CFO and COO, as interim CEO.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Priya Prasad was appointed as Interim Chief Executive Officer at Syra Health Corp.

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

the Board of Directors of the Company appointed Priya Prasad, the Company’s CFO and COO, as interim CEO.

View on SEC.gov

Syra Health Corp filing history →

Source: SEC EDGAR

accession 0001641172-25-015349

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.